High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran
Visceral leishmaniasis (VL) is a major health concern in patients with HIV infection in endemic areas of VL. In these areas, a substantial number of infected individuals are asymptomatic and the risk of acute VL infection in HIV/VL co-infected cases is high. The current study aimed to determine the...
Gespeichert in:
Veröffentlicht in: | Parasitology research (1987) 2018-08, Vol.117 (8), p.2591-2595 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2595 |
---|---|
container_issue | 8 |
container_start_page | 2591 |
container_title | Parasitology research (1987) |
container_volume | 117 |
creator | Rezaei, Z. Sarkari, B. Dehghani, M. Layegh Gigloo, A. Afrashteh, M. |
description | Visceral leishmaniasis (VL) is a major health concern in patients with HIV infection in endemic areas of VL. In these areas, a substantial number of infected individuals are asymptomatic and the risk of acute VL infection in HIV/VL co-infected cases is high. The current study aimed to determine the prevalence of asymptomatic VL infection among HIV-infected patients in Fars province, southern Iran. Subjects of the study were 251 HIV-confirmed patients who all were clinically asymptomatic for leishmaniasis. Blood samples were obtained from each participant. Anti-
Leishmania
antibodies were detected in the sera using ELISA. DNA was extracted from the buffy coat of each subject and PCR amplified, targeting an ITS-2 gene of
Leishmania
. PCR products were purified from the gel and were sequenced. Overall, 19 out of 251 (7.6%) HIV-infected patients were found to be infected with
Leishmania
, using serological or molecular methods. Anti-
Leishmania
antibodies were detected in 13 (5.2%) patients and leishmanial DNA in 8 (3.2%) of the patients. The sequence analysis of DNA-positive cases revealed the species of the parasite as
L. infantum
. The high prevalence of VL among the patients with HIV is a serious challenge which demands further attention to improve the prophylaxis and treatment measurements of VL/HIV co-infection and thereby promoting the life expectancy and quality of life of these patients. |
doi_str_mv | 10.1007/s00436-018-5949-9 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2049943217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A547146862</galeid><sourcerecordid>A547146862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-f17e4af9f8c18f8f01d8bb641915e15afcf53c154113fce3649b01deb8f23bdd3</originalsourceid><addsrcrecordid>eNp1ksFu1DAURS0EokPhA9ggS2xYkGIndhIvq4oyI43EBthajvM84yqxBzup1P_hQ3khpRUI5IUt-9yr56tLyGvOLjhjzYfMmKjqgvG2kEqoQj0hGy6qsuBKyqdkwxSeGefVGXmR8w1jvKmFeE7OStXWTDblhvzY-sORugTfZwj2jkZH89zZwQdvzUD34PNxNMEb6oMDO_kYqBljONDt7lux3kFPT2byEKZMB3_r8dEHOh2BQuhh9JaaBCYv3rc-W0hoPDwYZ58X_NqkTE8potzCe5rjjAYp0F0y4SV55syQ4dX9fk6-Xn_8crUt9p8_7a4u94UVlZoKxxsQxinXWt661jHet11XC664BC6Ns05WlkuBiTgLVS1Uhwx0rSurru-rc_Ju9cU5MI886XGZdxhMgDhnXTKhFObLG0Tf_oXexDkFnA6ppmzqkrfykTqYATSmFadk7GKqL6VouKjbukTq4h8Url_hxQDO4_0fAr4KbIo5J3D6lPxo0p3mTC_N0GszNDZDL83QCjVv7geeuxH6B8XvKiBQrkDGp3CA9Pij_7v-BJt4xQM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2072762185</pqid></control><display><type>article</type><title>High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran</title><source>SpringerNature Journals</source><creator>Rezaei, Z. ; Sarkari, B. ; Dehghani, M. ; Layegh Gigloo, A. ; Afrashteh, M.</creator><creatorcontrib>Rezaei, Z. ; Sarkari, B. ; Dehghani, M. ; Layegh Gigloo, A. ; Afrashteh, M.</creatorcontrib><description>Visceral leishmaniasis (VL) is a major health concern in patients with HIV infection in endemic areas of VL. In these areas, a substantial number of infected individuals are asymptomatic and the risk of acute VL infection in HIV/VL co-infected cases is high. The current study aimed to determine the prevalence of asymptomatic VL infection among HIV-infected patients in Fars province, southern Iran. Subjects of the study were 251 HIV-confirmed patients who all were clinically asymptomatic for leishmaniasis. Blood samples were obtained from each participant. Anti-
Leishmania
antibodies were detected in the sera using ELISA. DNA was extracted from the buffy coat of each subject and PCR amplified, targeting an ITS-2 gene of
Leishmania
. PCR products were purified from the gel and were sequenced. Overall, 19 out of 251 (7.6%) HIV-infected patients were found to be infected with
Leishmania
, using serological or molecular methods. Anti-
Leishmania
antibodies were detected in 13 (5.2%) patients and leishmanial DNA in 8 (3.2%) of the patients. The sequence analysis of DNA-positive cases revealed the species of the parasite as
L. infantum
. The high prevalence of VL among the patients with HIV is a serious challenge which demands further attention to improve the prophylaxis and treatment measurements of VL/HIV co-infection and thereby promoting the life expectancy and quality of life of these patients.</description><identifier>ISSN: 0932-0113</identifier><identifier>EISSN: 1432-1955</identifier><identifier>DOI: 10.1007/s00436-018-5949-9</identifier><identifier>PMID: 29860572</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibodies ; Biomedical and Life Sciences ; Biomedicine ; Buffy coat ; Complications and side effects ; Deoxyribonucleic acid ; Distribution ; DNA ; Enzyme-linked immunosorbent assay ; HIV ; HIV infections ; Human immunodeficiency virus ; Immunology ; Infections ; Leishmania ; Leishmaniasis ; Life span ; Medical Microbiology ; Microbiology ; Nucleotide sequence ; Original Paper ; Parasitic diseases ; Patients ; Polymerase chain reaction ; Prophylaxis ; Quality of life ; Risk factors ; Visceral leishmaniasis</subject><ispartof>Parasitology research (1987), 2018-08, Vol.117 (8), p.2591-2595</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>COPYRIGHT 2018 Springer</rights><rights>Copyright Springer Science & Business Media 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-f17e4af9f8c18f8f01d8bb641915e15afcf53c154113fce3649b01deb8f23bdd3</citedby><cites>FETCH-LOGICAL-c439t-f17e4af9f8c18f8f01d8bb641915e15afcf53c154113fce3649b01deb8f23bdd3</cites><orcidid>0000-0003-2045-9057</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00436-018-5949-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00436-018-5949-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29860572$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rezaei, Z.</creatorcontrib><creatorcontrib>Sarkari, B.</creatorcontrib><creatorcontrib>Dehghani, M.</creatorcontrib><creatorcontrib>Layegh Gigloo, A.</creatorcontrib><creatorcontrib>Afrashteh, M.</creatorcontrib><title>High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran</title><title>Parasitology research (1987)</title><addtitle>Parasitol Res</addtitle><addtitle>Parasitol Res</addtitle><description>Visceral leishmaniasis (VL) is a major health concern in patients with HIV infection in endemic areas of VL. In these areas, a substantial number of infected individuals are asymptomatic and the risk of acute VL infection in HIV/VL co-infected cases is high. The current study aimed to determine the prevalence of asymptomatic VL infection among HIV-infected patients in Fars province, southern Iran. Subjects of the study were 251 HIV-confirmed patients who all were clinically asymptomatic for leishmaniasis. Blood samples were obtained from each participant. Anti-
Leishmania
antibodies were detected in the sera using ELISA. DNA was extracted from the buffy coat of each subject and PCR amplified, targeting an ITS-2 gene of
Leishmania
. PCR products were purified from the gel and were sequenced. Overall, 19 out of 251 (7.6%) HIV-infected patients were found to be infected with
Leishmania
, using serological or molecular methods. Anti-
Leishmania
antibodies were detected in 13 (5.2%) patients and leishmanial DNA in 8 (3.2%) of the patients. The sequence analysis of DNA-positive cases revealed the species of the parasite as
L. infantum
. The high prevalence of VL among the patients with HIV is a serious challenge which demands further attention to improve the prophylaxis and treatment measurements of VL/HIV co-infection and thereby promoting the life expectancy and quality of life of these patients.</description><subject>Antibodies</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Buffy coat</subject><subject>Complications and side effects</subject><subject>Deoxyribonucleic acid</subject><subject>Distribution</subject><subject>DNA</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>HIV</subject><subject>HIV infections</subject><subject>Human immunodeficiency virus</subject><subject>Immunology</subject><subject>Infections</subject><subject>Leishmania</subject><subject>Leishmaniasis</subject><subject>Life span</subject><subject>Medical Microbiology</subject><subject>Microbiology</subject><subject>Nucleotide sequence</subject><subject>Original Paper</subject><subject>Parasitic diseases</subject><subject>Patients</subject><subject>Polymerase chain reaction</subject><subject>Prophylaxis</subject><subject>Quality of life</subject><subject>Risk factors</subject><subject>Visceral leishmaniasis</subject><issn>0932-0113</issn><issn>1432-1955</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1ksFu1DAURS0EokPhA9ggS2xYkGIndhIvq4oyI43EBthajvM84yqxBzup1P_hQ3khpRUI5IUt-9yr56tLyGvOLjhjzYfMmKjqgvG2kEqoQj0hGy6qsuBKyqdkwxSeGefVGXmR8w1jvKmFeE7OStXWTDblhvzY-sORugTfZwj2jkZH89zZwQdvzUD34PNxNMEb6oMDO_kYqBljONDt7lux3kFPT2byEKZMB3_r8dEHOh2BQuhh9JaaBCYv3rc-W0hoPDwYZ58X_NqkTE8potzCe5rjjAYp0F0y4SV55syQ4dX9fk6-Xn_8crUt9p8_7a4u94UVlZoKxxsQxinXWt661jHet11XC664BC6Ns05WlkuBiTgLVS1Uhwx0rSurru-rc_Ju9cU5MI886XGZdxhMgDhnXTKhFObLG0Tf_oXexDkFnA6ppmzqkrfykTqYATSmFadk7GKqL6VouKjbukTq4h8Url_hxQDO4_0fAr4KbIo5J3D6lPxo0p3mTC_N0GszNDZDL83QCjVv7geeuxH6B8XvKiBQrkDGp3CA9Pij_7v-BJt4xQM</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Rezaei, Z.</creator><creator>Sarkari, B.</creator><creator>Dehghani, M.</creator><creator>Layegh Gigloo, A.</creator><creator>Afrashteh, M.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2045-9057</orcidid></search><sort><creationdate>20180801</creationdate><title>High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran</title><author>Rezaei, Z. ; Sarkari, B. ; Dehghani, M. ; Layegh Gigloo, A. ; Afrashteh, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-f17e4af9f8c18f8f01d8bb641915e15afcf53c154113fce3649b01deb8f23bdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibodies</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Buffy coat</topic><topic>Complications and side effects</topic><topic>Deoxyribonucleic acid</topic><topic>Distribution</topic><topic>DNA</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>HIV</topic><topic>HIV infections</topic><topic>Human immunodeficiency virus</topic><topic>Immunology</topic><topic>Infections</topic><topic>Leishmania</topic><topic>Leishmaniasis</topic><topic>Life span</topic><topic>Medical Microbiology</topic><topic>Microbiology</topic><topic>Nucleotide sequence</topic><topic>Original Paper</topic><topic>Parasitic diseases</topic><topic>Patients</topic><topic>Polymerase chain reaction</topic><topic>Prophylaxis</topic><topic>Quality of life</topic><topic>Risk factors</topic><topic>Visceral leishmaniasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rezaei, Z.</creatorcontrib><creatorcontrib>Sarkari, B.</creatorcontrib><creatorcontrib>Dehghani, M.</creatorcontrib><creatorcontrib>Layegh Gigloo, A.</creatorcontrib><creatorcontrib>Afrashteh, M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parasitology research (1987)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rezaei, Z.</au><au>Sarkari, B.</au><au>Dehghani, M.</au><au>Layegh Gigloo, A.</au><au>Afrashteh, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran</atitle><jtitle>Parasitology research (1987)</jtitle><stitle>Parasitol Res</stitle><addtitle>Parasitol Res</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>117</volume><issue>8</issue><spage>2591</spage><epage>2595</epage><pages>2591-2595</pages><issn>0932-0113</issn><eissn>1432-1955</eissn><abstract>Visceral leishmaniasis (VL) is a major health concern in patients with HIV infection in endemic areas of VL. In these areas, a substantial number of infected individuals are asymptomatic and the risk of acute VL infection in HIV/VL co-infected cases is high. The current study aimed to determine the prevalence of asymptomatic VL infection among HIV-infected patients in Fars province, southern Iran. Subjects of the study were 251 HIV-confirmed patients who all were clinically asymptomatic for leishmaniasis. Blood samples were obtained from each participant. Anti-
Leishmania
antibodies were detected in the sera using ELISA. DNA was extracted from the buffy coat of each subject and PCR amplified, targeting an ITS-2 gene of
Leishmania
. PCR products were purified from the gel and were sequenced. Overall, 19 out of 251 (7.6%) HIV-infected patients were found to be infected with
Leishmania
, using serological or molecular methods. Anti-
Leishmania
antibodies were detected in 13 (5.2%) patients and leishmanial DNA in 8 (3.2%) of the patients. The sequence analysis of DNA-positive cases revealed the species of the parasite as
L. infantum
. The high prevalence of VL among the patients with HIV is a serious challenge which demands further attention to improve the prophylaxis and treatment measurements of VL/HIV co-infection and thereby promoting the life expectancy and quality of life of these patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29860572</pmid><doi>10.1007/s00436-018-5949-9</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-2045-9057</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0932-0113 |
ispartof | Parasitology research (1987), 2018-08, Vol.117 (8), p.2591-2595 |
issn | 0932-0113 1432-1955 |
language | eng |
recordid | cdi_proquest_miscellaneous_2049943217 |
source | SpringerNature Journals |
subjects | Antibodies Biomedical and Life Sciences Biomedicine Buffy coat Complications and side effects Deoxyribonucleic acid Distribution DNA Enzyme-linked immunosorbent assay HIV HIV infections Human immunodeficiency virus Immunology Infections Leishmania Leishmaniasis Life span Medical Microbiology Microbiology Nucleotide sequence Original Paper Parasitic diseases Patients Polymerase chain reaction Prophylaxis Quality of life Risk factors Visceral leishmaniasis |
title | High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A46%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20frequency%20of%20subclinical%20Leishmania%20infection%20among%20HIV-infected%20patients%20living%20in%20the%20endemic%20areas%20of%20visceral%20leishmaniasis%20in%20Fars%20province,%20southern%20Iran&rft.jtitle=Parasitology%20research%20(1987)&rft.au=Rezaei,%20Z.&rft.date=2018-08-01&rft.volume=117&rft.issue=8&rft.spage=2591&rft.epage=2595&rft.pages=2591-2595&rft.issn=0932-0113&rft.eissn=1432-1955&rft_id=info:doi/10.1007/s00436-018-5949-9&rft_dat=%3Cgale_proqu%3EA547146862%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2072762185&rft_id=info:pmid/29860572&rft_galeid=A547146862&rfr_iscdi=true |